27 Jul 2010 07:00
27 July 2010
Toumaz Limited
License agreement with Quanta Computer
Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in low cost, ultra low power wireless communications technology, has licensed its Sensium technology platform to Quanta Computer Inc. (TSE: 2382). Quanta, which is the world's largest notebook computer original design manufacturer, plans to use the Sensium, a real-time wireless monitor of the body's vital signs, for home healthcare applications.
The deal includes an upfront licence fee and the initial purchase of integrated circuits for prototyping and marketing.
Professor Chris Toumazou, Toumaz Chief Executive, commented:
"This is a key development for us and is a clear endorsement of our technology and strategy. We are developing an end-to-end technology platform consisting of innovative hardware, software and systems integration IP to enable "last metre" digital communications in a wide range of high-growth global markets, including remote medical monitoring."
Enquiries:
| Toumaz Holdings Limited | 020 7355 0036 |
| Chris Toumazou, Chief Executive Officer |
|
| Patrick Stephansen, Chief Financial Officer |
|
|
|
|
| FinnCap | 020 7600 1658 |
| Marc Young (Corporate Finance) |
|
| Brian Patient (Corporate Broking) |
|
|
|
|
| College Hill | 020 7457 2020 |
| Adrian Duffield/Rozi Morris |
|
About Toumaz (www.toumaz.com)
Toumaz is pioneering low cost, ultra-low power wireless technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.
Targeting the Healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in real-time wireless monitoring of the body's vital signs. Sensium has the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this creates new opportunities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible personalised healthcare.
Toumaz also uses its ultra low power expertise to design devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to leaders in the digital radio market, such as PURE.
Toumaz is an AIM listed company (AIM: TMZ) with development centres in Oxford, UK and Taipei City, Taiwan.